Metamorphosis: from the Newsletter to the Journal

Peter Winocour

doi:10.15277/bjdvd.2014.010

Metamorphosis: from the Newsletter to the Journal

Authors

Peter Winocour Consultant Diabetologist and ABCD executive, Queen Elizabeth II Hospital, Welwyn Garden City, Herts, UK

DOI:

https://doi.org/10.15277/bjdvd.2014.010

Downloads

HTML
PDF

Published

2014-04-01

Issue

Vol. 14 No. 1 (2014)

Section

ABCD News

License

Publish & Transfer of Copyright Agreement
For the mutual benefit and protection of the Author and the Journal Owner/Publisher it is necessary that the Author provides formal written Consent to Publish and Transfer of Copyright before publication of the Work.

Most read articles by the same author(s)

Janaka Karalliedde, Peter Winocour, Tahseen Chowdhury, Parijat De, Andrew H Frankel, Rosa Montero, Ana Pokrajac, Debasish Banerjee, Indranil Dasgupta, Damian Fogarty, Adnan Sharif, Mona Wahba, Patrick Mark, Sagen Zac-Varghese , Dipesh Patel, Stephen Bain, Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease , British Journal of Diabetes: Ahead of Print Articles
Umesh Dashora, Dipesh C Patel, Robert Gregory, Peter Winocour, Ketan Dhatariya, Susannah Rowles, Andrew Macklin, Gerry Rayman, Dinesh Nagi, Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose co-transporter inhibitors with insulin for treatment of type 1 diabetes (updated October 2020) , British Journal of Diabetes: Vol. 20 No. 2 (2020): December 2020
Thomas SJ Crabtree, Susannah Rowles, Stephanie Tarpey, Adele Kennedy, John Chalmers, Rahul Nayar, Amanda Lee, Ken Darzy, Peter Winocour, John Lindsay, Iskandar Idris, Ken Y Thong, Piya Sen Gupta, Amar Puttanna, Pranav Kumar, Robert EJ Ryder, On Behalf of ABCD Nationwide Audit Contributors, Reductions in alanine aminotransferase levels with liraglutide treatment are greatest in those with raised baseline levels and are independent of weight loss: real-world outcome data from the ABCD Nationwide Liraglutide Audit , British Journal of Diabetes: Vol. 19 No. 2 (2019): DECEMBER 2019
Peter Winocour, Diabetes and kidney disease: insult added to injury , British Journal of Diabetes: Vol. 18 No. 2 (2018): April / May / June 2018
Maggie S Hammersley, Gerry Rayman, Peter Winocour, Clive Weston, John Birkhead, On Behalf Of The Titan-ACS Steering Group, An evaluation of the safety and efficacy of a variable rate intravenous insulin infusion in the management of hyperglycaemia in acute coronary syndrome: experience of the TITAN-ACS , British Journal of Diabetes: Vol. 15 No. 4 (2015)
Thomas SJ Crabtree, Peter Winocour, Ken Darzy, Suzanne Phillips, Alison Evans, Anurita Rohilla, Rajeev Raghavan, Devesh Sennik, Alex Bickerton, Iskandar Idris, Mahender Yadagiri, Robert EJ Ryder, ABCD Canagliflozin Audit Contributors, Effects of canagliflozin are mostly observed at first follow-up, within 6 months of commencement: results for the ABCD canagliflozin audit , British Journal of Diabetes: Vol. 20 No. 2 (2020): December 2020

<< < 1 2